(Q36420111)

14 August 2017

Interleukin 2 exerts autocrine stimulation on murine T-cell leukaemia growth (English)

1 reference

14 August 2017

0 references

1 reference

Waldner CI

1

1 reference

14 August 2017

Mongini C

2

1 reference

14 August 2017

Alvarez E

3

1 reference

14 August 2017

Sánchez Lockhart M

4

1 reference

14 August 2017

Gravisaco MJ

5

1 reference

14 August 2017

Hajos SE

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

75

1 reference

14 August 2017

946-950

1 reference

14 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1997.165

14 August 2017

0 references

cites work

Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

The IL-2 receptor complex: its structure, function, and target genes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Mechanisms of action of cyclosporine: considerations for the treatment of autoimmune diseases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

T cell growth factor receptors. Quantitation, specificity, and biological relevance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Autocrine growth stimulation of a human T-cell lymphoma line by interleukin 2.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Autocrine growth factors and cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Interleukin-2: inception, impact, and implications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Growth factors as transforming proteins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Induction of anti-tumour immunity in syngeneic mice by a leukaemic cell line.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

T-Cell Growth Factor Gene: Lack of Expression in Human T-Cell Leukemia-Lymphoma Virus-Infected Cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Murine spontaneous T-cell leukemia constitutively expressing IL-2 receptor--a model for human T-cell malignancies expressing IL-2 receptor

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

Constitutive IL-2 expression in HTLV-I-infected leukaemic T cell lines

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2222760

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells

28 June 2018

1 reference

12 December 2020

Failure of regulation of Tac antigen/TCGF receptor on adult T-cell leukemia cells by anti-Tac monoclonal antibody

1 reference

12 December 2020

The murine IL 2 receptor. II. Monoclonal anti-IL 2 receptor antibodies as specific inhibitors of T cell function in vitro

1 reference

12 December 2020

Growth factors and cancer

1 reference

12 December 2020

Autocrine growth of a human T-cell line is inhibited by cyclosporin A

1 reference

12 December 2020

Murine T cell leukemia line in suspension culture

1 reference

12 December 2020

Inhibitory activity of soluble IL-2R in sera, ascites and culture supernatants from murine leukaemic cells

1 reference

12 December 2020

Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2

1 reference

12 December 2020

Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.165

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

1 reference